1
|
Acácio BR, Prada AL, Neto SF, Gomes GB, Perdomo RT, Nazario CED, Neto ES, Martines MAU, de Almeida DAT, Gasparotto Junior A, Amado JRR. Cytotoxicity, anti-inflammatory effect, and acute oral toxicity of a novel Attalea phalerata kernel oil-loaded nanocapsules. Biomed Pharmacother 2024; 174:116308. [PMID: 38626517 DOI: 10.1016/j.biopha.2024.116308] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2023] [Revised: 02/14/2024] [Accepted: 02/17/2024] [Indexed: 04/18/2024] Open
Abstract
The kernel oil of the Attalea phalerata Mart. Ex Spreng (Acurí) is traditionally used in several Latin American countries to treat respiratory problems, inflammation, and fever. However, it cannot be found on the literature any attend to use this oil in pharmaceutical formulation. In this paper, it was developed Acurí oil-loaded nanocapsules, and it was evaluated the cytotoxicity against cancer cells, the antinflammatory activity and the oral acute toxicity in rats. Acurí oil contains lauric acid as the predominant saturated fatty acid (433.26 mg/g) and oleic acid as the main unsaturated fatty acid (180.06 mg/g). The Acurí oil-loaded nanocapsules showed a size of 237 nm, a polydispersity index of 0.260, and a high ζ-potential of -78.75 mV. It was obtained an encapsulation efficiency of 88.77%, and the nanocapsules remain stable on the shelf for 180 days. The nanocapsules showed a rapid release profile (98.25% in 40 minutes). Nanocapsules at a dose of 10 mg/kg exhibit an anti-inflammatory effect similar to indomethacin at the same dose. The nanocapsules showed excellent antiproliferative effect and selectivity index against prostate tumor cells (IC50 2.09 µg/mL, SI=119.61) and kidney tumor cells (IC50 3.03 µg/mL, SI=82.50). Both Acurí oil and Acurí oil-loaded nanocapsules are nontoxic at a dose of 2000 mg/kg. Additionally, they reduce serum triglyceride and total cholesterol levels in rat and could find application in nutraceutical formulations. The Acurí oil-loaded nanocapsules emerge as a promising candidate for new antitumor therapies.
Collapse
Affiliation(s)
- Bianca Rodrigues Acácio
- Postgraduate Program in Pharmaceutical Sciences, Faculty of Pharmacy, Food, and Nutrition, Federal University of Mato Grosso do Sul, Brazil
| | - Ariadna Lafourcade Prada
- Postgraduate Program in Biotechnology, Faculty of Pharmacy, Food, and Nutrition, Federal University of Mato Grosso do Sul, Brazil
| | - Serafim Florentino Neto
- Laboratory of Innovation in Pharmaceutical Technology, Federal University of Amazonas, Manaus, AM, Brazil
| | - Giovana Bicudo Gomes
- Postgraduate Program in Pharmaceutical Sciences, Faculty of Pharmacy, Food, and Nutrition, Federal University of Mato Grosso do Sul, Brazil
| | - Renata Trentin Perdomo
- Postgraduate Program in Pharmaceutical Sciences, Faculty of Pharmacy, Food, and Nutrition, Federal University of Mato Grosso do Sul, Brazil
| | | | - Eduardo Sobieski Neto
- Postgraduate Program in Biotechnology, Institute of Chemistry, Federal University of Mato Grosso do Sul, Brazil
| | | | - Danielle Ayr Tavares de Almeida
- Postgraduate Program in Health Sciences. Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, MS, Brazil
| | - Arquimedes Gasparotto Junior
- Postgraduate Program in Health Sciences. Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, MS, Brazil
| | - Jesus Rafael Rodriguez Amado
- Postgraduate Program in Health Sciences. Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, MS, Brazil.
| |
Collapse
|
2
|
Pradhan R, Dubey SK, Puri A, Taliyan R. Development and validation of a stability‐indicating reversed‐phase–high‐performance liquid chromatography method for quantification of 2‐[1‐hexyloxyethyl]‐2‐devinyl pyropheophorbide‐a from lipid‐polymeric hybrid nanoparticles. SEPARATION SCIENCE PLUS 2022. [DOI: 10.1002/sscp.202200061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Affiliation(s)
- Rajesh Pradhan
- Department of Pharmacy Birla Institute of Technology and Science Pilani India
| | - Sunil Kumar Dubey
- Department of Pharmacy Birla Institute of Technology and Science Pilani India
- R&D Healthcare Division Emami Ltd. Kolkata India
| | - Anu Puri
- RNA Structure and Design Section, RNA Biology Laboratory (RBL), Center for Cancer Research National Cancer Institute – Frederick Frederick Maryland USA
| | - Rajeev Taliyan
- Department of Pharmacy Birla Institute of Technology and Science Pilani India
| |
Collapse
|
3
|
Bhattacharyya S, Nanjareddy L. Assessment of nano lipid carrier loaded transdermal patch of rizatriptan benzoate. DRUG METABOLISM AND BIOANALYSIS LETTERS 2022; 15:DMBL-EPUB-124296. [PMID: 35794742 DOI: 10.2174/2949681015666220609095706] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/24/2021] [Revised: 02/09/2022] [Accepted: 03/04/2022] [Indexed: 06/15/2023]
Abstract
BACKGROUND Migraine is a neurological disorder and is accompanied by different painful episodes. Hence the maintenance of a steady-state concentration of drug can be beneficial for the patients suffering with migraine. The present investigation focuses on the development of nano lipid carriers (NLCs) loaded transdermal patch of rizatriptan benzoate to sustain the effect of the drug for the enhancement of therapeutic effects. METHOD Stearic acid and peanut oil were used to make the NLCs. A central composite design was employed to observe the effect of formulation factors like solid lipid ratio, phase volume ratio, and concentration of surfactants on the formation of nanoparticles. The effects were evaluated for the responses like particle size and entrapment of the drug in the nanocarriers. The optimized formulation was subjected to compatibility, thermal, surface characteristics, and surface morphology studies. The optimized formulation was dispersed in HPMC 15CPS and PVP K30 polymer matrix and the transdermal patch was evaluated for its mechanical properties, drug release study, and skin irritation study. RESULTS The experimental design was suitable to produce nanosized stable lipid carriers of the drug with high drug entrapment. The drug and excipients were found to be compatible. The thermal and surface characteristics study proved the high loading of drug in the nanoparticles. The surface morphology study showed the formation of irregular-shaped NLCs. The transdermal patch had good mechanical properties. The ex vivo study of the formulated patch showed a sustained release of the drug over 24h. No skin irritation was reported from the transdermal patch. CONCLUSION Therefore, it can be concluded that the nanoparticles loaded transdermal patch of rizatriptan benzoate can be promising in controlling the divergent phases of migraine.
Collapse
Affiliation(s)
- Sayani Bhattacharyya
- Department of Pharmaceutics, Krupanidhi College of Pharmacy, Bengaluru, Karnataka, India
| | - Lavanya Nanjareddy
- Department of Pharmaceutics, Krupanidhi College of Pharmacy, Bengaluru, Karnataka, India
| |
Collapse
|
4
|
Nižić Nodilo L, Perkušić M, Ugrina I, Špoljarić D, Jakobušić Brala C, Amidžić Klarić D, Lovrić J, Saršon V, Safundžić Kučuk M, Zadravec D, Kalogjera L, Pepić I, Hafner A. In situ gelling nanosuspension as an advanced platform for fluticasone propionate nasal delivery. Eur J Pharm Biopharm 2022; 175:27-42. [PMID: 35489667 DOI: 10.1016/j.ejpb.2022.04.009] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2021] [Revised: 03/23/2022] [Accepted: 04/24/2022] [Indexed: 11/28/2022]
Abstract
In this work we present the development of in situ gelling nanosuspension as advanced form for fluticasone propionate nasal delivery. Drug nanocrystals were prepared by wet milling technique. Incorporation of drug nanocrystals into polymeric in situ gelling system with pectin and sodium hyaluronate as constitutive polymers was fine-tuned attaining appropriate formulation surface tension, viscosity and gelling ability. Drug nanonisation improved the release profile and enhanced formulation mucoadhesive properties. QbD approach combining formulation and administration parameters resulted in optimised nasal deposition profile, with 51.8% of the dose deposited in the middle meatus, the critical region in the treatment of rhinosinusitis and nasal polyposis. Results obtained in biocompatibility and physico-chemical stability studies confirmed the leading formulation potential for safe and efficient nasal corticosteroid delivery.
Collapse
Affiliation(s)
- Laura Nižić Nodilo
- University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia
| | - Mirna Perkušić
- University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia
| | - Ivo Ugrina
- University of Split, Faculty of Science, Split, Croatia
| | | | | | | | - Jasmina Lovrić
- University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia
| | - Vesna Saršon
- Jadran-galenski laboratorij d.d, Rijeka, Croatia
| | | | - Dijana Zadravec
- Department of Diagnostic and Interventional Radiology, Sestre milosrdnice University Hospital Center, University of Zagreb, Zagreb, Croatia
| | - Livije Kalogjera
- ENT Department, Zagreb School of Medicine; University Hospital Center "Sestre milosrdnice", Zagreb, Croatia
| | - Ivan Pepić
- University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia.
| | - Anita Hafner
- University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia.
| |
Collapse
|
5
|
AlMasoud N, Bakheit AH, Alshammari MFM, Abdel-Aziz HA, AlRabiah H. Loratadine. PROFILES OF DRUG SUBSTANCES, EXCIPIENTS, AND RELATED METHODOLOGY 2022; 47:55-90. [PMID: 35396016 DOI: 10.1016/bs.podrm.2021.10.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
Loratadine, 4-(8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidinecarboxylic acid ethyl ester, is an antihistamine drug with long-acting effects and has limited selectivity for peripheral H1 receptors. It is widely used for the prevention of allergic diseases such as rhinitis chronic urticaria, and asthma. This chapter discusses, by a critical extensive review of the literature, the description of loratadine in terms of its names, formulae, elemental composition, appearance, methods of preparation. The profile contains physicochemical properties of Loratadine, including pKa value, solubility and X-ray powder diffraction. In addition, it involves Fourier transform infrared spectrometry, nuclear magnetic resonance spectroscopy and mass spectroscopy for functional groups and structural confirmation of. The chapter also includes methods of analysis of the drug such as compendial, titrimetric, electrochemical, spectroscopic, chromatographic and capillary electrophoretic methods. The chapter also covers clinical applications of the drug such as its uses, doses, ADME profiles and mechanism of action.
Collapse
Affiliation(s)
- Najla AlMasoud
- Department of Chemistry, College of Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia
| | - Ahmed H Bakheit
- Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia; Department of Chemistry, Faculty of Science and Technology, Al-Neelain University, Khartoum, Sudan.
| | - Munif Farhan M Alshammari
- Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia
| | - Hatem A Abdel-Aziz
- Department of Applied Organic Chemistry, National Research Center, Dokki, Egypt
| | - Haitham AlRabiah
- Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia
| |
Collapse
|
6
|
Pınar SG, Canpınar H, Tan Ç, Çelebi N. A new nanosuspension prepared with wet milling method for oral delivery of highly variable drug Cyclosporine A: Development, optimization and in vivo evaluation. Eur J Pharm Sci 2022; 171:106123. [PMID: 35017012 DOI: 10.1016/j.ejps.2022.106123] [Citation(s) in RCA: 10] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2021] [Revised: 12/30/2021] [Accepted: 01/03/2022] [Indexed: 11/03/2022]
Abstract
Cyclosporine A (CsA) is a cyclic polypeptide, that has been widely used for immunosuppression. This study aims to develop nanosuspension for oral administration of CsA using the wet milling (WM) method one of the top-down technologies. The WM method was optimized by studying the effects of critical process parameters for WM on the particle size (PS), particle size distribution (PDI), and zeta potential (ZP) of nanosuspensions using the Design of Experiment (DoE) approach. Nanosuspension was developed using hydroxypropyl methylcellulose (HPMC) and sodium dodecyl sulfate (SDS) and in vitro characterization studies were performed. In vitro dissolution and in vivo pharmacokinetic studies were conducted with biorelevant media (fasted and fed state simulated fluids) and fasted and fed states in rats, respectively. In vivo immunological studies were also performed. PS, PDI, and ZP values for nanosuspension were approximately 600 nm, 0.4, -25 mV, respectively. The solubility of CsA was increased by 4.5-folds by nanosuspensions. Dissolution studies showed that nanosuspension had higher dissolution than the commercial product in the FeSSIF medium. The pharmacokinetic study indicated that AUC0-24 values of CsA nanosuspension were to be 2.09 and 5.51-fold higher than coarse powder in fasted and fed conditions, respectively. Immunological studies were carried out after oral administration of nanosuspension for 21 days, the ratio of CD4+/CD8+ was found to be more acceptable than the commercial product. These results demonstrated that nanosuspension is a promising approach for increasing the bioavailability and avoiding the food effect on absorption of CsA which one of the highly variable drugs.
Collapse
Affiliation(s)
- Sıla Gülbağ Pınar
- Gazi University, Faculty of Pharmacy, Department of Pharmaceutical Technology, Etiler, 06330, Yenimahalle, Ankara, Turkey; Süleyman Demirel University, Faculty of Pharmacy, Department of Pharmaceutical Technology, 32260, Çünür, Isparta, Turkey
| | - Hande Canpınar
- Hacettepe University, Cancer Institute, Department of Basic Oncology, 06100, Sıhhiye, Ankara, Turkey
| | - Çağman Tan
- Hacettepe University, Faculty of Medicine, Institute of Child Health, 06100, Sıhhiye, Ankara, Turkey
| | - Nevin Çelebi
- Gazi University, Faculty of Pharmacy, Department of Pharmaceutical Technology, Etiler, 06330, Yenimahalle, Ankara, Turkey; Başkent University, Faculty of Pharmacy, Department of Pharmaceutical Technology, 06790, Etimesgut, Ankara, Turkey.
| |
Collapse
|
7
|
TAMADDON L, MOHAMADI N, BAVARSAD N. Preparation and Characterization of Mucoadhesive Loratadine Nanoliposomes for Intranasal Administration. Turk J Pharm Sci 2021; 18:492-497. [PMID: 34496556 PMCID: PMC8430403 DOI: 10.4274/tjps.galenos.2020.33254] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2020] [Accepted: 11/09/2020] [Indexed: 12/01/2022]
Abstract
Objectives The present study aimed to formulate and characterize mucoadhesive liposomes for intranasal delivery of loratadine. In particular, the formulation was aimed to improve the drug bioavailability and efficacy. Materials and Methods Liposomes were prepared by thin-film hydration method, with soybean phosphatidylcholine and cholesterol as main components. Liposomes were coated with chitosan solution at a concentration of 0.05% and 0.1%, w/v. The formulations were assessed for particle size, polydispersity index (PDI), encapsulation efficiency (EE), thermodynamic behavior, in vitro drug release, mucoadhesiveness, and stability. Results Particle size analysis showed that the vesicles of uncoated and coated liposomes with 0.05% and 0.1% chitosan were characterized by size of 193±3.3 nm, 345±4.6, and 438±7.3 nm, respectively. Size distribution for developed formulations was in the acceptable range (PDI <0.7). EE was recorded to be approximately 80%. Chitosan-coated liposomes demonstrated slower release rate as compared to uncoated liposomes. Drug release kinetics profile for all the formulations followed a zero-order model. Chitosan coating improved mucoadhesiveness by more than 3-fold as compared to uncoated liposomes. However, no significant differences were recorded between mucin adsorption behavior of 0.05% and 0.1% chitosan-coated liposomes (p>0.05). For stability studies, liposomes were stored at 4°C for 3 months, and changes in particle diameter, PDI, and EE % were recorded. No significant alternations were reported in particles size, PDI, and drug leakage of coated liposomes. Conclusion Liposomes coated with 0.05% chitosan were chosen as the optimum formulation, which demonstrated a significant potential for overcoming the nasal drug delivery limits for short residence time and mucociliary clearance.
Collapse
Affiliation(s)
- Lena TAMADDON
- Department of Pharmaceutics, Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
| | - Negar MOHAMADI
- Department of Pharmaceutics, Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
| | - Neda BAVARSAD
- Department of Pharmaceutics, Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
- Nanotechnology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
| |
Collapse
|
8
|
Neto SF, Prada AL, Achod LDR, Torquato HFV, Lima CS, Paredes-Gamero EJ, Silva de Moraes MO, Lima ES, Sosa EH, de Souza TP, Amado JRR. α-amyrin-loaded nanocapsules produce selective cytotoxic activity in leukemic cells. Biomed Pharmacother 2021; 139:111656. [PMID: 34243603 DOI: 10.1016/j.biopha.2021.111656] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2020] [Revised: 04/13/2021] [Accepted: 04/21/2021] [Indexed: 10/21/2022] Open
Abstract
INTRODUCTION Amyrins are triterpenes that have attractive pharmacological potential; however, their low water solubility and erratic stomach absorption hinders their use as a drug. The aim of this paper was to develop a novel α-amyrin-loaded nanocapsule for intestinal delivery and evaluate, preliminarily, its cytotoxic ability against leukemic cells. MATERIAL AND METHODS Five nanocapsule formulations were designed by the solvent displacement-evaporation method. Poly-ε-caprolactone, Eudragit® E100, and Kollicoat® Mae 100 P were used as film-former materials. Particle size, polydispersity index (PdI), zeta potential, and the pH of all formulations were measured. The cytotoxic potential of the nanocapsules was evaluated in vitro using different leukemic lineages RESULTS: Nanocapsules coated with Kollicoat® Mae 100 P presented the smallest particle size (130 nm), the lowest zeta-potential (-38 mV), and the narrowest size distribution (PdI = 0.100). The entrapment efficiency was 65.47%, while the loading capacity was 2.40%. Nanocapsules release 100% of α-amyrin in 40 min (pH 7.4), by using a possible mechanism of swelling-diffusion. The formulation showed excellent on-shelf physicochemical stability during one year. Additionally, nanocapsules produced a selective cytotoxic effect on a human leukemia lineage Kasumi-1, an acute myeloid leukemia cell line, and produced cell death by apoptosis CONCLUSION: α-amyrin-loaded nanocapsules appear to be a promising nanoformulation that could be used against leukemia.
Collapse
Affiliation(s)
- Serafim Florentino Neto
- Laboratory of Innovation and Development in Pharmaceutical Technology (LIDETEF), Faculty of Pharmaceutical Sciences, Universidade Federal do Amazonas, Av. Rodrigo Octavio Ramos, 6200, Coroado, Manaus, AM CEP 69077-000, Brazil
| | - Ariadna Lafourcade Prada
- Laboratory of Innovation and Development in Pharmaceutical Technology (LIDETEF), Faculty of Pharmaceutical Sciences, Universidade Federal do Amazonas, Av. Rodrigo Octavio Ramos, 6200, Coroado, Manaus, AM CEP 69077-000, Brazil
| | - Leonardo Domingo Rosales Achod
- Laboratory of Innovation and Development in Pharmaceutical Technology (LIDETEF), Faculty of Pharmaceutical Sciences, Universidade Federal do Amazonas, Av. Rodrigo Octavio Ramos, 6200, Coroado, Manaus, AM CEP 69077-000, Brazil
| | | | - Cauê Santos Lima
- Biochemistry Department, Universidade Federal de São Paulo, Rua Três de Maio 100, São Paulo, SP, CEP 04044-020, Brazil
| | - Edgar Julian Paredes-Gamero
- Biochemistry Department, Universidade Federal de São Paulo, Rua Três de Maio 100, São Paulo, SP, CEP 04044-020, Brazil; Pharmaceutical Sciences Post-Graduation Program, Faculty of Pharmacy, Food and Nutrition, Universidade Federal do Mato Grosso do Sul, Av. Costa e Silva, Pioneiros, Campo Grande, MS CEP 79070-900, Brazil
| | - Maria Oneide Silva de Moraes
- Thematic Microscopy and Nanotechnology Laboratory (LTMN), Instituto Nacional de Pesquisas da Amazônia (INPA), Av. Bem Te ví, 8-406. Petrópolis, Manaus, AM 69067-001, Brazil
| | - Emerson Silva Lima
- Laboratory of Innovation and Development in Pharmaceutical Technology (LIDETEF), Faculty of Pharmaceutical Sciences, Universidade Federal do Amazonas, Av. Rodrigo Octavio Ramos, 6200, Coroado, Manaus, AM CEP 69077-000, Brazil
| | - Edgar Hernandez Sosa
- Department of Biochemistry & Molecular Biology, Dalhousie University, Sir Charles Tupper Medical Building, 5850 College Street, Halifax, Nova Scotia B3H 4R2, Canada
| | - Tatiane Pereira de Souza
- Laboratory of Innovation and Development in Pharmaceutical Technology (LIDETEF), Faculty of Pharmaceutical Sciences, Universidade Federal do Amazonas, Av. Rodrigo Octavio Ramos, 6200, Coroado, Manaus, AM CEP 69077-000, Brazil
| | - Jesus Rafael Rodriguez Amado
- Laboratory of Pharmaceutical Technology (LTF), Faculty of Pharmacy, Food and Nutrition, Universidade Federal do Mato Grosso do Sul, Av. Costa e Silva, Pioneiros, Campo Grande, MS CEP 79070-900, Brazil.
| |
Collapse
|
9
|
Abstract
The field of nanomedicine continues to grow with new technologies and formulations in development for several disease states. Much research focuses on the use of injectable nanomedicines for treatment of neoplasms; however, there are several formulations in development that use nanotechnology that can be administered enterally for noncancer indications. These nanomedicine treatments have been developed for systemic drug delivery or local drug delivery along the gastrointestinal tract. This Review gives a brief overview of the alimentary canal and highlights new research in nanomedicine in noncancer disease states delivered via enteral routes of administration. Relevant recent research is summarized on the basis of the targeted site of action or absorption, including the buccal, sublingual, stomach, small intestine, and large intestine areas of the alimentary canal. The benefits of nanodrug delivery are discussed as well as barriers and challenges for future development in the field.
Collapse
Affiliation(s)
- Brianna Cote
- Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, 2730 S. Moody Avenue, RLSB, Portland, Oregon 97201, United States
| | - Deepa Rao
- School of Pharmacy, Pacific University, 222 SE 8th Avenue, Suite 451, Hillsboro, Oregon 97123, United States
| | - Adam W G Alani
- Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, 2730 S. Moody Avenue, RLSB, Portland, Oregon 97201, United States.,Biomedical Engineering Department, Oregon Health & Science University, 2730 S. Moody Avenue, RLSB, Portland, Oregon 97201, United States.,Knight Cancer Institute, Oregon Health & Science University, 2730 S. Moody Avenue, RLSB, Portland, Oregon 97201, United States
| |
Collapse
|
10
|
Rahman M, Almalki WH, Afzal O, Alfawaz Altamimi AS, Kazmi I, Al-Abbasi FA, Choudhry H, Alenezi SK, Barkat MA, Beg S, Kumar V, Alhalmi A. Cationic Solid Lipid Nanoparticles of Resveratrol for Hepatocellular Carcinoma Treatment: Systematic Optimization, in vitro Characterization and Preclinical Investigation. Int J Nanomedicine 2020; 15:9283-9299. [PMID: 33262588 PMCID: PMC7695602 DOI: 10.2147/ijn.s277545] [Citation(s) in RCA: 26] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2020] [Accepted: 10/29/2020] [Indexed: 11/23/2022] Open
Abstract
Aim The present study focuses on the development and evaluation of the resveratrol (RV)-loaded cationic solid lipid nanoparticles (RV-c-SLNs) for the management of hepatocellular carcinoma (HCC). Materials and Methods Optimization of formulation was performed using factorial design, and further in vitro drug release, cytotoxicity, biodistribution, in vivo preclinical, and biochemical evaluation were carried out. Results The optimized formulation exhibited uniform size, homogeneous disparity, positive zeta potential, and stability over 12-week storage at 25°C/60% RH. The in vitro drug release and cytotoxicity study showed 60% drug release within the first 6 hours and comparatively higher cytotoxicity on HepG2 cell line by resveratrol-solid lipid nanoparticle (RV-SLN) as compared to the RV solution. In addition, an anticancer action and biodistribution study on a rat model of HCC showed significant reduction of tumor volume and higher accumulation in the tumor tissue from RV-c-SLN (P<0.01) over RV solution and RV-SLN. Furthermore, RV-c-SLN showed significant down-regulation in the levels of pro-inflammatory cytokines and balancing of antioxidant enzymes. Histopathological investigation showed reduced occurrence of hepatic nodules, necrosis formation, infiltration of inflammatory cells, blood vessels inflammation, and cell swelling. Conclusion Overall, the obtained results construed that RV-c-SLN with improved antitumor activity as clearly evident from in vitro, in vivo, and biochemical investigations.
Collapse
Affiliation(s)
- Mahfoozur Rahman
- Department of Pharmaceutical Sciences, Shalom Institute of Health & Allied Sciences, Sam Higginbottom University of Agriculture, Technology & Sciences, Allahabad, India
| | - Waleed H Almalki
- Department of Pharmacology and Toxicology, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia
| | - Obaid Afzal
- Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, AlKharj 11942, Saudi Arabia
| | | | - Imran Kazmi
- Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Fahad A Al-Abbasi
- Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Hani Choudhry
- Department of Biochemistry, Cancer Metabolism & Epigenetic Unit, Faculty of Science, King Fahd Center for Medical Research, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Sattam K Alenezi
- Department of Pharmacology & Toxicology, Unaizah College of Pharmacy, Qassim University, Qassim, Saudi Arabia
| | - Md Abul Barkat
- Department of Pharmaceutics, College of Pharmacy, University of Hafr Al Batin, Al Jamiah, Hafr Al Batin, Saudi Arabia
| | - Sarwar Beg
- Department of Pharmaceutics, School of Pharmaceutical Education and Research, Nanomedicine Research Lab, Jamia Hamdard, New Delhi, India
| | - Vikas Kumar
- Department of Pharmaceutical Sciences, Shalom Institute of Health & Allied Sciences, Sam Higginbottom University of Agriculture, Technology & Sciences, Allahabad, India
| | - Abdulsalam Alhalmi
- Department of Pharmaceutical Science, Collage of Pharmacy, Aden University, Aden, Yemen
| |
Collapse
|
11
|
Hashem FM, Abd Allah FI, Abdel-Rashid RS, Hassan AAA. Glibenclamide nanosuspension inhaler: development, in vitro and in vivo assessment. Drug Dev Ind Pharm 2020; 46:762-774. [DOI: 10.1080/03639045.2020.1753062] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Affiliation(s)
- Fahima M. Hashem
- Pharmaceutics Department, Faculty of Pharmacy, Helwan University, Cairo, Egypt
| | - Fathy I. Abd Allah
- International Center for Bioavailability, Pharmaceutical and Clinical Research (ICBR), Cairo, Egypt
- Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Al-Azhar university, Cairo, Egypt
| | | | - Abdelsabour A. A. Hassan
- International Center for Bioavailability, Pharmaceutical and Clinical Research (ICBR), Cairo, Egypt
- Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Al-Azhar university, Cairo, Egypt
- Metered Dose Inhaler Department (MDI), Cairo, Egypt
- Arab Drug Company for pharmaceuticals and chemical industries (ADCO), Cairo, Egypt
| |
Collapse
|
12
|
Amado JRR, Prada AL, Diaz JG, Souto RNP, Arranz JCE, de Souza TP. Development, larvicide activity, and toxicity in nontarget species of the Croton linearis Jacq essential oil nanoemulsion. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH INTERNATIONAL 2020; 27:9410-9423. [PMID: 31916152 DOI: 10.1007/s11356-020-07608-8] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/01/2019] [Accepted: 01/01/2020] [Indexed: 05/10/2023]
Abstract
In this study, the essential oil (EO) from leaves of Croton linearis Jacq was extracted and characterized by GC/MS. The EO hydrophilic-lipophilic balance required (rHLB) for nanoemulsion (NE) development was determined by the Griffin' method. For evaluating the larvicidal effect against Aedes aegypti, the preparation process of NE was optimized, using a central composite design. It was also evaluated the possible toxic effect of NE in nontarget species. The leaves of C. linearis contain 1.50% of EO, enclosing 61 volatile compounds, mainly eucalyptol (26.66%). The best surfactant, oil:water ratio (4.5-5.0-91.5; % w:w:w), allows to achieve the optimal NE, using a stirring speed of 800 rpm, the addition rate of 0.5 ml/min, and a stirring time of 30 min. NE (with particle size = 163 nm) showed a larvicide effect (LC50 = 17.86 μg/mL) more potent than the whole EO (LC50 = 64.24 μg/mL). NE showed neither hemolytic effect nor cytotoxicity, and it was classified as a nontoxic product, according to the OECD class toxicity test (IC50 > 2000 mg/kg). This product arises in a new green bio-larvicide that could be used for mosquito control.
Collapse
Affiliation(s)
- Jesus Rafael Rodriguez Amado
- Department of Pharmacy, Faculty of Natural Sciences, Universidad de Oriente, Patricio Lumumba S/N, CP 90500, Santiago de Cuba, Cuba.
- Laboratory of Innovation and Development in Pharmaceutical Technology, University of Amazonas, Ave. Rodrigo Otavio, Japiim, Ramos 6200, Coroado,, Manaus, AM, CEP69077-000, Brazil.
| | - Ariadna Lafourcade Prada
- Department of Pharmacy, Faculty of Natural Sciences, Universidad de Oriente, Patricio Lumumba S/N, CP 90500, Santiago de Cuba, Cuba
- Biological Sciences Department, Federal University of Amapá, Rod. Juscelino Kubitschek, KM 02, S/N - Jardim Marco Zero, Macapá, AP, 68903-419, Brazil
| | - Jesus Garcia Diaz
- Department of Pharmacy, Faculty of Natural Sciences, Universidad de Oriente, Patricio Lumumba S/N, CP 90500, Santiago de Cuba, Cuba
| | - Raimundo Nonato Picanço Souto
- Biological Sciences Department, Federal University of Amapá, Rod. Juscelino Kubitschek, KM 02, S/N - Jardim Marco Zero, Macapá, AP, 68903-419, Brazil
| | - Júlio Cesar Escalona Arranz
- Department of Pharmacy, Faculty of Natural Sciences, Universidad de Oriente, Patricio Lumumba S/N, CP 90500, Santiago de Cuba, Cuba
| | - Tatiane Pereira de Souza
- Laboratory of Innovation and Development in Pharmaceutical Technology, University of Amazonas, Ave. Rodrigo Otavio, Japiim, Ramos 6200, Coroado,, Manaus, AM, CEP69077-000, Brazil
| |
Collapse
|
13
|
Ambrus R, Alshweiat A, Csóka I, Ovari G, Esmail A, Radacsi N. 3D-printed electrospinning setup for the preparation of loratadine nanofibers with enhanced physicochemical properties. Int J Pharm 2019; 567:118455. [DOI: 10.1016/j.ijpharm.2019.118455] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2019] [Revised: 06/18/2019] [Accepted: 06/20/2019] [Indexed: 11/26/2022]
|
14
|
Efendy Goon D, Sheikh Abdul Kadir SH, Latip NA, Ab Rahim S, Mazlan M. Palm Oil in Lipid-Based Formulations and Drug Delivery Systems. Biomolecules 2019; 9:E64. [PMID: 30781901 PMCID: PMC6406477 DOI: 10.3390/biom9020064] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2018] [Revised: 02/07/2019] [Accepted: 02/07/2019] [Indexed: 12/18/2022] Open
Abstract
Palm oil is natural oil packed with important compounds and fatty acids ready to be exploited in lipid-based formulations and drug delivery. Palm oil and palm kernel oil contain long-chain and medium-chain triglycerides, respectively, including phytonutrients such as tocotrienol, tocopherol and carotenes. The exploitation of these compounds in a lipid-based formulation would be able to address hydrophobicity, lipophilicity, poor bioavailability and low water-solubility of many current drugs. The utilisation of palm oil as part of the drug delivery system seemed to improve the bioavailability and solubility of the drug, stabilising emulsification of formulation between emulsifier and surfactant, promoting enhanced drug permeability and performance, as well as extending the shelf-life of the drug. Despite the complexity in designing lipid-based formulations, palm oil has proven to offer dynamic behaviour in providing versatility in drug design, form and delivery. However, the knowledge and application of palm oil and its fractions in lipid-based formulation are scarce and interspersed. Therefore, this study aims to focus on the research and outcomes of using palm oil in lipid-based formulations and drug delivery systems, due to the importance of establishing its capabilities and benefits.
Collapse
Affiliation(s)
- Danial Efendy Goon
- Department of Biochemistry, Faculty of Medicine, Universiti Teknologi MARA (UiTM), Cawangan Selangor, 47000 Sungai Buloh, Selangor, Malaysia.
- Institute of Medical Molecular Biotechnology (IMMB), Faculty of Medicine, Universiti Teknologi MARA (UiTM), Cawangan Selangor, 47000 Sungai Buloh, Selangor, Malaysia.
| | - Siti Hamimah Sheikh Abdul Kadir
- Department of Biochemistry, Faculty of Medicine, Universiti Teknologi MARA (UiTM), Cawangan Selangor, 47000 Sungai Buloh, Selangor, Malaysia.
- Institute of Medical Molecular Biotechnology (IMMB), Faculty of Medicine, Universiti Teknologi MARA (UiTM), Cawangan Selangor, 47000 Sungai Buloh, Selangor, Malaysia.
| | - Normala Ab Latip
- Atta-ur-Rahman Institute for Natural Products Discovery (AuRIns), Faculty of Pharmacy, Universiti Teknologi MARA, 42300 Puncak Alam, Cawangan Selangor, Selangor, Malaysia.
| | - Sharaniza Ab Rahim
- Department of Biochemistry, Faculty of Medicine, Universiti Teknologi MARA (UiTM), Cawangan Selangor, 47000 Sungai Buloh, Selangor, Malaysia.
| | - Musalmah Mazlan
- Department of Biochemistry, Faculty of Medicine, Universiti Teknologi MARA (UiTM), Cawangan Selangor, 47000 Sungai Buloh, Selangor, Malaysia.
| |
Collapse
|
15
|
Alshora DH, Ibrahim MA, Elzayat E, Almeanazel OT, Alanazi F. Rosuvastatin calcium nanoparticles: Improving bioavailability by formulation and stabilization codesign. PLoS One 2018; 13:e0200218. [PMID: 29985967 PMCID: PMC6037357 DOI: 10.1371/journal.pone.0200218] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2018] [Accepted: 06/21/2018] [Indexed: 11/17/2022] Open
Abstract
Purpose Rosuvastatin calcium (ROSCa) is a poorly soluble drug with bioavailability not exceeding 20%. Decreasing the particle size may enhance its solubility, dissolution rate and bioavailability. Therefore, the aim of the current study is to prepare ROSCa nanoparticles by wet milling technique using planetary ball mill. The codesign between formulation and stabilization of nanoparticles was studied to achieve both high dissolution as well as bioavailability. Methodology ROSCa nanosuspensions was prepared by wet milling technique using planetary ball mill, by applying milling ball size of 0.1 mm at speed of 800 rpm for 3 cycles each cycle composed of 10 minutes. HPMC, PVP k-30, pluronic F-127, Tween 80 and PEG 6000 were used as stabilizers. The nanosuspensions were then freeze-dried, and the dried nanoparticles were evaluated for particle size, zeta potential, in-vitro dissolution test, XRPD and in-vivo study. Results ROSCa nanoparticles stabilized with 10% PVP (P3) had a good stability with smallest particle size, which in turn enhanced the dissolution rate. The particle size of the leading formula was 461.8 ± 16.68 nm with zeta potential of -31.8 ± 7.22 mV compared to untreated drug that has a particle size of 618μm. The percent of ROSCa dissolved after 1 hour enhanced significantly which reached 72% and 58.25% for leading nanoparticle formula and untreated ROSCa, respectively (P < 0.05). The in-vivo study of ROSCa from the leading nanoparticle formula showed a significant enhancement in the Cmax after 2 h (82.35 ng/ml) compared to 9.2 ng/ml for untreated drug. Conclusion Wet milling technique is a successful method to prepare ROSCa nanoparticles. From different stabilizer used, PVP (10%) was able to produce stable nanoparticle with small particle size which significantly enhance the dissolution rate and pharmacokinetics parameters of ROSCa.
Collapse
Affiliation(s)
- Doaa H Alshora
- Kayyali chair for Pharmaceutical Industries, Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia
| | - Mohamed A Ibrahim
- Kayyali chair for Pharmaceutical Industries, Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.,Department of Pharmaceutics, College of pharmacy, Al-Azhar University, Assiut, Egypt
| | - Ehab Elzayat
- Kayyali chair for Pharmaceutical Industries, Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia
| | - Osaid T Almeanazel
- Kayyali chair for Pharmaceutical Industries, Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia
| | - Fars Alanazi
- Kayyali chair for Pharmaceutical Industries, Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia
| |
Collapse
|
16
|
Yang B, Wei C, Yang Y, Wang Q, Li S. Evaluation about wettability, water absorption or swelling of excipients through various methods and the correlation between these parameters and tablet disintegration. Drug Dev Ind Pharm 2018; 44:1417-1425. [DOI: 10.1080/03639045.2018.1453519] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Affiliation(s)
- Baixue Yang
- School of Pharmacy, Shenyang Pharmaceutical University, Benxi, Liaoning, PR China
| | - Chen Wei
- School of Pharmacy, Shenyang Pharmaceutical University, Benxi, Liaoning, PR China
| | - Yang Yang
- School of Pharmacy, Shenyang Pharmaceutical University, Benxi, Liaoning, PR China
| | - Qifang Wang
- School of Pharmacy, Shenyang Pharmaceutical University, Benxi, Liaoning, PR China
| | - Sanming Li
- School of Pharmacy, Shenyang Pharmaceutical University, Benxi, Liaoning, PR China
| |
Collapse
|
17
|
Pandey P, Rahman M, Bhatt PC, Beg S, Paul B, Hafeez A, Al-Abbasi FA, Nadeem MS, Baothman O, Anwar F, Kumar V. Implication of nano-antioxidant therapy for treatment of hepatocellular carcinoma using PLGA nanoparticles of rutin. Nanomedicine (Lond) 2018; 13:849-870. [DOI: 10.2217/nnm-2017-0306] [Citation(s) in RCA: 72] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Abstract
Aim: The present work describes the development of poly(lactic co-glycolic acid) (PLGA) nanoparticles (NPs) of rutin (RT) for the treatment of hepatocellular carcinoma in rats. Materials & methods: RT-loaded PLGA NPs (RT-PLGA-NPs) were prepared by double emulsion evaporation method. Further these are optimized by Box–Behnken design. PLGA NPs were evaluated for size, polydispersity index, drug-loading capacity, entrapment, gastric stability, in vitro drug release, in vivo preclinical studies and biochemical studies. Results: Preclinical evaluation of RT-PLGA-NPs for anticancer activity through oral route exhibited significant improvement in hepatic, hematologic and renal biochemical parameters. Highly superior activity was observed in regulating oxidative stress and inflammatory markers, antioxidant enzymes, cytokines and inflammatory mediators and their role on plasma membrane ATPases responsible for destruction in liver tissues. Conclusion: Histopathological evaluation indicated reduced incidence of hepatic nodules, necrosis formation, infiltration of inflammatory cells, blood vessel inflammation and cell swelling with RT-PLGA-NP treatment along with considerable downregulation in the levels of proinflammatory cytokines.
Collapse
Affiliation(s)
- Preeti Pandey
- Natural Product Drug Discovery Laboratory, Department of Pharmaceutical Sciences, Faculty of Health Sciences, Sam Higginbottom University of Agriculture, Technology & Sciences, Allahabad-211007, UP, India
| | - Mahfoozur Rahman
- Department of Pharmaceutical Sciences, Shalom Institute of Health & Allied Sciences, Sam Higginbottom University of Agriculture, Technology & Sciences, Allahabad-211007, UP, India
| | - Prakash Chandra Bhatt
- Centre for Advanced Research in Pharmaceutical Sciences, Microbial & Pharmaceutical Biotechnology Laboratory, Faculty of Pharmacy, Jamia Hamdard, New Delhi-110062, India
| | - Sarwar Beg
- Product Development Research, Jubilant Generics Limited, Noida-201301, UP, India
| | - Basudev Paul
- Product Development Research, Jubilant Generics Limited, Noida-201301, UP, India
| | - Abdul Hafeez
- Glocal School of Pharmacy, Glocal University, Saharanpur, UP, India
| | - Fahad A Al-Abbasi
- Department of Biochemistry, Cancer Metabolism & Epigenetic Unit, Faculty of Science, Center of Innovation in Personalized Medicine, Cancer & Mutagenesis Unit, King Fahd Center for Medical Research, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Muhammad Shahid Nadeem
- Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Othman Baothman
- Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Firoz Anwar
- Department of Biochemistry, Cancer Metabolism & Epigenetic Unit, Faculty of Science, Center of Innovation in Personalized Medicine, Cancer & Mutagenesis Unit, King Fahd Center for Medical Research, King Abdulaziz University, Jeddah, Saudi Arabia
- Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Vikas Kumar
- Natural Product Drug Discovery Laboratory, Department of Pharmaceutical Sciences, Faculty of Health Sciences, Sam Higginbottom University of Agriculture, Technology & Sciences, Allahabad-211007, UP, India
| |
Collapse
|